Editor's Note Compared to married patients, those who were divorced, separated, or widowed had a 40% greater chance of dying or developing a functional disability in the first 2 years after cardiac surgery, in this study. Characterizing the association between marital status and postoperative function may be useful for counseling…

Read More

Editor's Note The Food and Drug Administration on October 15 issued a safety alert that heater-cooler devices have been associated with Nontuberculous Mycobacteria infections, primarily in patients undergoing cardiothoracic surgical procedures. Devices include: oxygenator heat exchangers cardioplegia heat exchangers warming/cooling blankets. Between January 2010 and August 2015, the FDA received…

Read More

A highlight of this year’s OR Manager Conference in Nashville, Tennessee, was an interactive hybrid OR exhibit with products from 15 companies. During a special Town Hall on Thursday, October 8, members of the Hybrid OR Steering Committee answered questions from conference attendees seeking information about what’s involved in planning…

Read More

Editor's Note Patients age 90 years and older with aortic stenosis can benefit from transcatheter aortic valve replacement (TAVR), this study finds. TAVR patients had a comparable risk of mortality as those who did not have the procedure, and quality of life improved within 6 months.  

Read More

Editor's Note Robotic-assisted cardiac surgery had significantly reduced length of stay, complications, and mortality compared with nonrobotic surgery in this study. Robotic-assisted had a higher median cost than nonrobotic surgery ($39,030 vs $36,340). The results show that robotic-assisted is as safe as nonrobotic cardiac surgery and offers surgeons an additional…

Read More

Editor's Note The Food and Drug Administration on August 5 categorized the recall of 6,912 units of Medtronic Cardiovascular Surgery’s EnVeo R loading system as Class I, the most serious. The loading system is used with the CoreValve Evolut R replacement heart valve. The recall was issued over concerns about…

Read More

Editor's Note The Food and Drug Administration on August 5 issued a Safety Communication on serious adverse events linked to left ventricular assist devices (LVADs). Two implantable LVADs are approved by the FDA (HeartMate II by Thoratec Corporation and HeartWare HVAD by HeartWare Inc), and serious events have been associated…

Read More

Editor's Note Patients exposed to radiation during cardiac computed tomographic angiography had evidence of deoxyribonucleic acid (DNA) damage that was associated with cell death, DNA damage in cells, and activation of genes involved in DNA repair, in this study. Most cells damaged by the CT scan were repaired, but a…

Read More

Editor's Note The use of hybrid coronary revascularization is safe and effective, with faster recovery and similar outcomes compared to conventional coronary artery bypass grafting, this study finds. The 30-day composite of mortality, myocardial infarction, or stroke was similar for both procedures, as was mortality during a 3-year follow-up period.…

Read More

Editor's Note This study found that current and former smoking by surgical patients negatively influenced outcomes following major cardiovascular and oncology procedures. Current smokers had higher odds of overall, pulmonary, wound, and septic/shock complications compared with nonsmokers. The odds of having adverse outcomes were significantly lower in former smokers, but…

Read More